Recent research from Mount Sinai has unveiled concerning evidence that fetuses are likely exposed to significantly higher levels of per- and polyfluoroalkyl substances (PFAS), commonly referred to as “forever chemicals,” than previously understood. By analysing umbilical cord blood samples, the study identified a wider array of these compounds, suggesting a more extensive environmental impact on fetal health.
Comprehensive Analysis of PFAS
Historically, testing of umbilical cord blood has focused on a limited selection of PFAS compounds, such as perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS). However, the Mount Sinai team undertook a novel “non-targeted analysis” of 120 umbilical cord blood samples, previously only found to contain up to four PFAS compounds. Their methodology successfully detected 42 distinct PFAS compounds across the samples, revealing total PFAS levels that far exceed earlier estimates.
Shelley Liu, an associate professor at the Icahn School of Medicine and co-author of the study, expressed the urgency of these findings, stating, “Babies are exposed to many more PFAS than we previously thought. It’s particularly important to understand because it is a very vulnerable period when fetuses are exposed.”
Understanding the Implications of PFAS
PFAS are a vast family of approximately 15,000 synthetic chemicals widely used to impart water-, stain-, and grease-resistance to various products. These compounds have been associated with numerous severe health issues, including cancer, birth defects, reduced immune response, hypercholesterolemia, and kidney disease. Their designation as “forever chemicals” stems from their persistence in the environment and inability to naturally decompose.
A review encompassing 40 studies has shown that PFAS have been consistently detected in umbilical cord blood samples, with a staggering 30,000 samples reviewed collectively. Elevated levels of PFAS in mothers have been correlated with increased infant mortality, low birth weights, and potential obesity in later life. Moreover, fetal exposure has been linked to long-term health concerns, such as cancer, neurological disorders, and cardiovascular diseases.
Regulatory Challenges and Testing Limitations
The older “legacy” PFAS compounds, like PFOA and PFOS, were prevalent until their phase-out in the last decade. In their place, newer PFAS variants have been introduced, with manufacturers often asserting, albeit without robust evidence, that these alternatives are less harmful. Concurrently, there is a noticeable lag in regulatory methods that monitor both blood and water for these emerging PFAS, as evidenced by the US Environmental Protection Agency (EPA), which primarily tests for only 30-40 compounds despite the identification of thousands by independent researchers.
The Mount Sinai study serves as a crucial comparison between traditional analysis and the newer non-targeted approach, highlighting that comprehensive testing invariably uncovers a greater number of PFAS compounds. While the EPA has recently certified a blood test capable of detecting 53 PFAS compounds, 31 of those identified by the Mount Sinai study were not included in this list.
Health Concerns and Future Research Directions
Although the current study did not directly investigate health outcomes associated with the elevated PFAS levels, Liu acknowledged that higher concentrations in blood are generally linked to increased health risks. The samples were sourced from a federal initiative known as the Home study, which monitors individuals’ PFAS exposure alongside their health trajectories.
David Andrews, acting chief science officer at the Environmental Working Group, remarked on the implications of the findings, stating, “The harms to babies polluted with a complete mixture of PFAS chemicals has likely been underestimated due to the inability to measure these compounds.” He added that this research underscores the urgent need for stringent health-protective regulations, given that lax oversight can lead to infants being born with harmful chemical burdens.
Why it Matters
The findings from this study illuminate a critical public health issue, exposing the potential for widespread chemical exposure during a highly vulnerable developmental stage. As understanding of PFAS compounds continues to evolve, it is imperative for regulatory bodies to enhance their testing methodologies and implement more robust protections. The health implications for fetuses and infants demand urgent attention, as the legacy of environmental contamination could have lasting repercussions on future generations.
